🇺🇸 FDA
Patent

US 11642401

Activation of resident memory T cells for cancer immunotherapy

granted A61KA61K2039/585A61K2239/31

Quick answer

US patent 11642401 (Activation of resident memory T cells for cancer immunotherapy) held by Regents of the University of Minnesota expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/585, A61K2239/31, A61K2239/38, A61K2239/57